News

HT Hospital Technologies agreement calls for minimum sales of 150,000 units the first year, 200,000 units the second, and 250,000 units the third year. Robert McCullough, CEO of

Daiichi Sankyo has been engaged in joint research with MorphoSys on its advanced HuCAL phage display antibody library technologies since March 2006. It exercised its option which included

The settlement will include payment by Lilly of $15 million plus a term that will ensure that Alaska is treated as favorably as any other state that may

Sagent’s Cefepime for injection will be available in 1g and 2g single dose vials. Sagent will begin marketing and shipping cefepime immediately. The introduction of Cefepime for injection

CE Mark approval gives Evalve the ability to train and educate physicians in Europe on the use of the MitraClip device increasing the number of patients who will

LowTop’s low profile design, coupled with its unique ‘no torque’ locking feature, is said to offer surgeons a user-friendly pedicle screw system complete with poly axial and fixed

The investment was led by Sante Ventures and was joined by previous investors, including Memphis Biomed Ventures, the Southern Appalachian Fund, and the Nashville Capital Network. Protein Discovery

In addition to studying the impact of genetics on warfarin dosing, Harvard-Partners Center for Genetics and Genomics (HPCGG) seeks to examine whether a patient’s metabolomic profile might also

Star technology is a production technology that is particularly useful for the production of recombinant human antibodies and proteins. It has a potentially broad application and is effective